ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 159

Assessing Agreement Among Measures of Inflammation Detected on Magnetic Resonance Imaging, Ultrasound and Clinical Findings in the Feet of Patients with Early Rheumatoid Arthritis

Karen A. Beattie1, George Ioannidis2, Sydney Scheffler3, Saara Totterman4, Edward Schreyer5 and Maggie Larche1, 1Medicine, McMaster University, Hamilton, ON, Canada, 2St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 3McMaster University, Hamilton, ON, Canada, 4Radiology, VirtualScopics Inc., Rochester, NY, 5QMetrics Technologies, Rochester, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Clinical, Inflammation, Magnetic resonance imaging (MRI), rheumatoid arthritis (RA) and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Imaging of Rheumatic Diseases - Poster I: Ultrasound and Emerging Technologies

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: In metatarsalphalangeal (MTP) joints 2-5 of patients with early rheumatoid arthritis (RA), we aimed to assess the agreement between i) Magnetic Resonance Imaging (MRI) and ultrasound (US) findings of inflammation, and ii) clinical swelling and each of MRI and US findings of inflammation.

Methods:  Participants with early RA (ACR criteria) were recruited. Clinical exam was followed by an MRI scan (1.0 Tesla peripheral MRI) and US scan of MTPs 2-5 of the most symptomatic foot. MRI scans were scored by a blinded radiologist using OMERACT RAMRIS criteria for bone marrow edema (BME) (0-3) and synovitis (0-3). Using OMERACT criteria, US images were assessed for synovial thickening (0-3), synovial flow (power Doppler (PD)) (0-3), and erosions (present/absent) in each MTP joint by a rheumatologist, who also assessed swelling (presence/absence) in each MTP. To compare inflammation on MRI versus US, kappa statistics were determined for: MRI synovitis and US synovial thickening, MRI synovitis and US PD, MRI BME and US synovial thickening, and MRI BME and US PD. Agreements between clinical swelling and each MRI and US feature of inflammation (0 = absent, ≥1 on MRI or US = present) were assessed using kappa statistics. The proportions of imaging-detected inflammation also detected clinically were determined.

Results: The study included 33 women, 6 men; mean age 51.6 years (standard deviation=10.2). Table 1 presents weighted kappa statistics for agreement between MRI and US findings of inflammation. Like agreement between synovitis on MRI and US PD, agreement between MRI detected BME and US PD was fair to good. Table 2 presents agreement between clinical swelling and inflammation on MRI and US. Neither US synovial thickness nor MRI synovitis agreed with clinical swelling. There was fair agreement (kappas 0.2322-0.3664) between clinical swelling and each of US PD and MRI BME, but this was stronger in some joints than others. Table 1: Agreement in Inflammation detected by MRI and Ultrasound

 

Joint

kappa

95% CI

MRI synovitis vs.

US synovial thickening

MTP2

0.0415

-0.0804, 0.1634

MTP3

0.0683

-0.0545, 0.1910

MTP4

0.2541*

0.0135, 0.4947

MTP5

0.2905*

-0.0971, 0.6781

MRI synovitis vs.

US power Doppler

MTP2

0.2838*

0.0112, 0.5565

MTP3

0.4700*

0.2417, 0.6984

MTP4

0.3358*

0.0367, 0.6349

MTP5

0.2506*

-0.0942, 0.5954

MRI BME vs.

US synovial thickening

MTP2

0.0376

-0.0820, 0.1572

MTP3

0.0285

-0.0733, 0.1303

MTP4

0.2400*

0.0045, 0.4755

MTP5

0.1784*

-0.1199, 0.4766

MRI BME vs.

US power Doppler

MTP2

0.2680*

-0.0130, 0.5490

MTP3

0.2729*

0.0191, 0.5266

MTP4

0.3294*

0.0286, 0.6302

MTP5

0.2290*

-0.0987, 0.5567

*denotes kappa is significant (p<0.05) Table 2: Agreement in Swelling on Clinical Exam compared to Ultrasound and MRI findings of Inflammation

 

Joint

Kappa

95% CI

Prevalence Index

Bias Index

% of imaging detected inflammation also detected clinically

Clinical swelling vs.

US synovial thickening

MTP2

0.0612

-0.0852, 0.2077

0.2250

0.5250

37.1

MTP3

0.0428

-0.1341, 0.2197

-0.1220

0.4878

21.4

MTP4

0.0267

-0.1409, 0.1943

-0.5610

0.3415

6.3

MTP5

0.1323

-0.1874, 0.4520

–
0.7561

0.1463

12.5

Clinical swelling vs.

US power Doppler

MTP2

0.1659

-0.1093, 0.4411

-0.5366

-0.2195

60.0

MTP3

0.3664*

-0.0022, 0.7351

-0.6829

-0.0732

60.0

MTP4

0.2870*

-0.2124, 0.7864

-0.8537

0.0488

25.0

MTP5

0.2322*

-0.2113, 0.6757

-0.8293

0.0732

20.0

Clinical Swelling vs. MRI Synovitis

MTP2

-0.0680

-0.3544, 0.2184

-0.1000

0.2000

31.8

MTP3

0.1000

-0.1467, 0.3467

-0.3000

0.3000

25.0

MTP4

0.0625

-0.1601, 0.2851

-0.6500

0.2500

8.3

MTP5

-0.0843

-0.1799, 0.0113

-0.7750

0.1250

0

Clinical Swelling vs. MRI BME

MTP2

0.2799*

-0.0272, 0.5869

-0.2368

0.0789

50.0

MTP3

0.2714*

-0.0012, 0.5440

-0.3421

0.2368

35.3

MTP4

0.0579

-0.1639, 0.2796

-0.6316

0.2632

8.3

MTP5

0.1857

-0.2098, 0.5812

-0.7895

0.1053

16.7

*denotes kappa is significant (p<0.05) There was fair agreement between ultrasound PD and MRI features of BME and synovitis; and ultrasound synovitis and MRI synovitis and BME, but only for MTP4 and 5. There was similar fair agreement between clinical swelling and imaging features of inflammation (BME and PD), but poor for clinical swelling and imaging measures of swelling.

Conclusion: These findings confirm agreements in the imaging parameters of inflammation and suggest that imaging by US and MRI are better than clinical assessment in determining synovial inflammation.


Disclosure: K. A. Beattie, None; G. Ioannidis, None; S. Scheffler, None; S. Totterman, None; E. Schreyer, QMetrics Technologies, 4; M. Larche, Abbvie, 2,Canadian Rheumatology Ultrasound Society, 6,Abbvie, 8.

To cite this abstract in AMA style:

Beattie KA, Ioannidis G, Scheffler S, Totterman S, Schreyer E, Larche M. Assessing Agreement Among Measures of Inflammation Detected on Magnetic Resonance Imaging, Ultrasound and Clinical Findings in the Feet of Patients with Early Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/assessing-agreement-among-measures-of-inflammation-detected-on-magnetic-resonance-imaging-ultrasound-and-clinical-findings-in-the-feet-of-patients-with-early-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-agreement-among-measures-of-inflammation-detected-on-magnetic-resonance-imaging-ultrasound-and-clinical-findings-in-the-feet-of-patients-with-early-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology